American Biomanufacturing Summit

Join us in San Francisco – we are at booth 44.

Come and see us at the American Biomanufacturing Summit and hear how Skyland PIMS can help your team with smarter process and data management for clinical and commercial manufacturing.

Read our info sheet “Process Performance Qualification (PPQ): Early adoption of digital process systems puts you in control” to learn how our process information management system, PIMS for short, bridges the data gap between preclinical PD and clinical and commercial-stage manufacturing to ensure that processes are controlled throughout a product’s lifecycle.

As a centralized, single source of truth for your critical manufacturing process data, Skyland PIMS provides data transparency and embedded analytics to both expedite and reduce the risk of your scale-up and tech transfer.

Ken Forman will be leading a workshop “Speed up your development pipeline and get your time back with digital transformation” on Thursday, April 13, 9:25AM PDT.

And don’t forget to join our panel “Effectively navigating the FDA digital landscape across QA/RA” moderated by Scott Weiss on Thursday, April 13, 3:05PM PDT.

We look forward to connecting with you at ABS!

About American Biomanufacturing Summit: It is designed to provide biopharmaceutical executives with current trends, strategic insights and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain and logistics. Network with over 150+ of your peers as we explore strategies to maximize efficiency while remaining compliant in an ever-evolving environment.

Ken Forman, Senior Director, Product Strategy

Ken has over 28 years of experience and expertise in IT, Operations, and Product & Project Management focused in the software and pharmaceutical space.

Prior to joining Skyland Analytics, Ken served as Director, Project Management, NAM at BIOVIA Dassault Systemes and held multiple director positions at Aegis Analytical. Previously, he was Director of IT at Rally Software Development, Director of Commercial Operations at Fischer Imaging and Director of IT at Allos Therapeutics and Genomica. In addition to his work accomplishments, he is a Certified Scrum Master.

Ken holds a BSc in Computer Science from Cal Poly and an MBA from the University of Colorado, Denver.

Scott Weiss, Vice President, Business Development and Open Innovation

Scott is responsible for developing IDBS’ expanding network of technology and channel partners. He joined IDBS in 2004 and has held senior leadership roles in consultancy, product management and strategy.

Prior to joining IDBS, Scott spent over 20 years in the pharmaceutical industry, where he led multiple drug-development programs from conceptualization to entry in clinical trials and has authored over 30 peer-reviewed scientific papers and patents.

He obtained his PhD in Psychology from the University of Leeds, specializing in Neuroscience.

Sep Mohseni, Director of Sales, West Coast

Sep Mohseni has over 10 years of experience bringing innovative solutions to the Pharmaceutical, Hospital, CDMO/CMO, Medical Device, and Analytical Testing industries.  

Her expertise in identifying the right IT solutions to address diverse and complex challenges makes her a respected advisor in maximizing value and creating pathways to realize improved service, product quality, and patient safety.  

Prior to IDBS, Sep held roles at Spectra and Infinity Laboratories where she aligned with strategic partners and helped clients define a pathway forward to accelerate product launch and decrease risk in the pharmaceutical and biotech manufacturing process.